PRK and LASIK reduces retinal image quality

Article

Performing photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) reduces the retinal image quality in myopic patients.

Performing photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) reduces the retinal image quality in myopic patients, declared a paper in the Journal of Cataract and Refractive Surgery.

The comparative case series, headed by Dr Meritxell Vilaseca, Universitat Politècnica de Catalunya, Terrassa, Barcelona Institute of Ocular Microsurgery, Barcelona, Spain, assessed 34 myopic eyes that underwent PRK and 55 myopic eyes that underwent LASIK.

Preoperatively and 3 months after PRK or LASIK optical quality was assessed with a clinical double-pass system. The team calculated the modulation transfer function (MTF), retinal image quality parameters (MTF cut-off frequency, Strehl ratio), and intraocular scattering [objective scatter index (OSI)].

PRK and LASIK demonstrated a statistically significant reduction on retinal image quality. However, there were no differences in reduction between the two techniques.

In the PRK group the MTF decreased by a factor of 1.50 and in the LASIK group it decreased by 1.32. The Strehl ratio was decreased by 1.10 and 1.07 for the PRK and LASIK group, respectively.

PRK and LASIK caused an increase in the objective scatter index by factors of 1.48 and 1.57, respectively. The preoperative refraction and the OSI were strongly linked.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.